GLM101 (Part B, Open-label) clinical trials

A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG

This study is testing a new medicine called GLM101 for people with PMM2-CDG, a rare genetic condition. We want to see if it's safe and helps improve symptoms like balance and movement, comparing it to a dummy treatment.